| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.86B | -2.5% |
| Cost of Revenue | $2.05B | -1.9% |
| Gross Profit | $2.81B | -2.9% |
| R&D Expense | $834.9M | -0.6% |
| SG&A Expense | $776.0M | +17.6% |
| Operating Income | $1.03B | -15.7% |
| Pre-tax Income | $1.06B | -11.8% |
| Income Tax | $91.4M | -26.7% |
| Net Income | $973.6M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.28B | -14.6% |
| Accounts Receivable | $656.8M | -22.1% |
| Inventory | $1.52B | +23.4% |
| Current Assets | $3.96B | -7.2% |
| Total Assets | $7.73B | -1.6% |
| Current Liabilities | $1.21B | -16.3% |
| Stockholders' Equity | $6.20B | +1.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $788.3M | -22.1% |
| Capital Expenditures | $244.3M | -20.6% |
| Investing Cash Flow | -$145.1M | +69.5% |
| Financing Cash Flow | -$840.6M | -72.7% |
| Free Cash Flow | $544.0M | -22.8% |
| -10.0% |
| EPS (Basic) | $5.06 | -10.1% |
| EPS (Diluted) | $5.04 | -10.2% |